We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
201
DELISTED
Radius Health, Inc.
RDUS
$302K 0.13%
24,375
-2,240
-8% -$32.3K
BCYC
202
Bicycle Therapeutics
BCYC
$276M
$297K 0.13%
7,130
-379
-5% -$13.3K
INBX
203
DELISTED
Inhibrx, Inc. Common Stock
INBX
$290K 0.13%
8,695
-458
-5% -$13.9K
GBT
204
DELISTED
Global Blood Therapeutics, Inc.
GBT
$289K 0.13%
11,358
-1,038
-8% -$30.5K
ZLAB icon
205
Zai Lab
ZLAB
$2.1B
$284K 0.13%
2,692
-245
-8% -$35.2K
ARCT icon
206
Arcturus Therapeutics
ARCT
$164M
$283K 0.12%
5,913
-316
-5% -$14.2K
ACAD icon
207
Acadia Pharmaceuticals
ACAD
$4.35B
$279K 0.12%
16,785
-1,545
-8% -$29.8K
DTM icon
208
DT Midstream
DTM
$14.3B
$279K 0.12%
+6,030
New +$264K
SAGE
209
DELISTED
Sage Therapeutics
SAGE
$278K 0.12%
6,280
-573
-8% -$26.3K
CCXI
210
DELISTED
ChemoCentryx, Inc.
CCXI
$276K 0.12%
16,142
-843
-5% -$13.1K
LEGN icon
211
Legend Biotech
LEGN
$3.73B
$266K 0.12%
5,265
-266
-5% -$11.1K
EPZM
212
DELISTED
Epizyme, Inc
EPZM
$266K 0.12%
51,919
-4,755
-8% -$28.9K
BLUE
213
DELISTED
bluebird bio
BLUE
$261K 0.11%
1,053
-97
-8% -$27.7K
ALXO icon
214
ALX Oncology
ALXO
$272M
$260K 0.11%
3,526
-192
-5% -$12.8K
ATRA icon
215
Atara Biotherapeutics
ATRA
$69.5M
$259K 0.11%
580
-30
-5% -$10.7K
KPTI icon
216
Karyopharm Therapeutics
KPTI
$161M
$258K 0.11%
2,958
-271
-8% -$28.1K
ZNTL icon
217
Zentalis Pharmaceuticals
ZNTL
$321M
$253K 0.11%
3,794
-198
-5% -$11.4K
ASND icon
218
Ascendis Pharma A/S
ASND
$16.6B
$252K 0.11%
1,581
-83
-5% -$11.4K
ALLK
219
DELISTED
Allakos
ALLK
$248K 0.11%
2,340
-122
-5% -$10.9K
IDYA icon
220
IDEAYA Biosciences
IDYA
$3.54B
$247K 0.11%
9,675
-502
-5% -$11.7K
KYMR icon
221
Kymera Therapeutics
KYMR
$9.05B
$247K 0.11%
4,205
-216
-5% -$12.5K
ADAP
222
DELISTED
Adaptimmune Therapeutics
ADAP
$245K 0.11%
47,350
-2,469
-5% -$11.1K
KOD icon
223
Kodiak Sciences
KOD
$2.62B
$240K 0.11%
2,498
-138
-5% -$12.8K
MIRM icon
224
Mirum Pharmaceuticals
MIRM
$6.96B
$239K 0.11%
11,984
-618
-5% -$10.1K
RGNX icon
225
Regenxbio
RGNX
$622M
$237K 0.1%
5,660
-302
-5% -$10.9K
7 8
9
10 11

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.